Jean-Baptiste Lamy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jean-Baptiste Lamy has a total of 236 co-authors. Here are the top co-authors by number of shared publications:
- Alain Venot
UFR SMBH Université Paris 13
14 shared publications Alain Venot
11 shared publications- Catherine Duclos
Université Sorbonne Paris Nord, APHP, Avicenne, Santé Publique, INSERM, Sorbonne Université, Laboratoire d’Informatique Médicale et d’Ingénierie des connaissances en e-Santé, LIMICS, 93017, Bobigny, France
9 shared publications Hector Falcoff
SFTG Recherche (Société de Formation Thérapeutique du Généraliste), Paris, 75013, France
9 shared publications- Rosy Tsopra
Clinical Bioinformatics Laboratory, Imagine Institute, Université Paris Cité, INSERM UMR1163, 24 Boulevard du Montparnasse, Paris, F-75006, France, 33 668169844
9 shared publications Tsopra Rosy
Centre de Recherche des Cordeliers, Université Paris Cité, Sorbonne Université, Inserm, Paris, F-75006, France
9 shared publications
Latest Publications
- Open Access
- 29 June 2026
- Published by IOS Press
- Vol. 338, 539-543
Assessing the Concordance Between LLM-Based ICD-10 Coding and a Drug Database for Antihypertensive Drug Contraindications: A Weighted Inter-Rater Agreement Study
Background: Manual ICD-10 coding of drug contraindications is resource-intensive and difficult to scale. Large language models (LLMs) have shown early promise for clinical information extraction, but their reliability for structured pharmacological coding relative to validated expert databases remains unknown. Objective: To assess the concordance between LLM-based automated ICD-10 coding and Thésorimed drug database1 for antihypertensive drug contraindications. Methods: Contraindications were extracted from Summary of Product Characteristics free-text documents for 301 antihypertensive drugs using a retrieval-augmented generation pipeline and aligned against Thésorimed ICD-10 codes. Agreement was assessed using a binary kappa (κ1, entity presence) and a hierarchical weighted kappa (κ2, ICD-10 code concordance) on 5,074 entities. Results: Entity-level agreement was slight (κ1 = -0.30), reflecting structural differences in source coverage. Code-level agreement among matched pairs was substantial (κ2 = 0.70, Po = 0.871), with 76.9% identical codes. Conclusion: When both sources identify the same contraindication, LLM-based coding shows substantial concordance with expert-curated ICD-10 assignments. However, low entity-level agreement highlights important differences in coverage and representation between sources.
- 29 June 2026
- Published by IOS Press
- Vol. 338, 539-543
Open AccessAssessing the Concordance Between LLM-Based ICD-10 Coding and a Drug Database for Antihypertensive Drug Contraindications: A Weighted Inter-Rater Agreement Study
Background: Manual ICD-10 coding of drug contraindications is resource-intensive and difficult to scale. Large language models (LLMs) have shown early promise for clinical information extraction, but their reliability for structured pharmacological coding relative to validated expert databases remains unknown. Objective: To assess the concordance between LLM-based automated ICD-10 coding and Thésorimed drug database1 for antihypertensive drug contraindications. Methods: Contraindications were extracted from Summary of Product Characteristics free-text documents for 301 antihypertensive drugs using a retrieval-augmented generation pipeline and aligned against Thésorimed ICD-10 codes. Agreement was assessed using a binary kappa (κ1, entity presence) and a hierarchical weighted kappa (κ2, ICD-10 code concordance) on 5,074 entities. Results: Entity-level agreement was slight (κ1 = -0.30), reflecting structural differences in source coverage. Code-level agreement among matched pairs was substantial (κ2 = 0.70, Po = 0.871), with 76.9% identical codes. Conclusion: When both sources identify the same contraindication, LLM-based coding shows substantial concordance with expert-curated ICD-10 assignments. However, low entity-level agreement highlights important differences in coverage and representation between sources.
- Open Access
- 6 October 2025
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 25 (1) , 1
Correction: ABiMed: An intelligent and visual clinical decision support system for medication reviews and polypharmacy management
- 6 October 2025
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 25 (1) , 1
Open AccessCorrection: ABiMed: An intelligent and visual clinical decision support system for medication reviews and polypharmacy management
- Open Access
- 2 October 2025
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 25 (1) , 1
Correction: Adaptive questionnaires for facilitating patient data entry in clinical decision support systems: methods and application to STOPP/ START v2
- 2 October 2025
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 25 (1) , 1
Open AccessCorrection: Adaptive questionnaires for facilitating patient data entry in clinical decision support systems: methods and application to STOPP/ START v2
- Open Access
- 2 October 2025
- Published by IOS Press
- Vol. 332, 42-46
From Guidelines to Code: Formalizing STOPP/START Criteria Using LLMs and RAG for Clinical Decision Support
STOPP/START v3 is a set of criteria for optimizing therapy for elderly patients with polypharmacy. Implementing these criteria in prescribing software requires to formalize them, which is a difficult task. This project aimed to automate the formalization of these criteria using large language models (LLMs), specifically leveraging Retrieval-Augmented Generation (RAG) for enhanced accuracy. We employed DeepSeek and GPT-4o-mini for entity extraction, code mapping to ICD-10, LOINC, and ATC, and the generation of executable Python code. A preliminary evaluation conducted on a subset of rules yielded a notably high F1-score (0.90, 0.92, 1 for drug, disease and observation entity mapping respectively and perfect results for medical entity extraction and code logic consistency). These results confirm the model’s effectiveness in accurately transforming complex clinical rules into executable code. In conclusion, we successfully automated the creation of executable code from medical guidelines, proving that LLMs, supported by RAG, can be effective for automating clinical decision support tasks and formalizing medical rules
- 2 October 2025
- Published by IOS Press
- Vol. 332, 42-46
Open AccessFrom Guidelines to Code: Formalizing STOPP/START Criteria Using LLMs and RAG for Clinical Decision Support
STOPP/START v3 is a set of criteria for optimizing therapy for elderly patients with polypharmacy. Implementing these criteria in prescribing software requires to formalize them, which is a difficult task. This project aimed to automate the formalization of these criteria using large language models (LLMs), specifically leveraging Retrieval-Augmented Generation (RAG) for enhanced accuracy. We employed DeepSeek and GPT-4o-mini for entity extraction, code mapping to ICD-10, LOINC, and ATC, and the generation of executable Python code. A preliminary evaluation conducted on a subset of rules yielded a notably high F1-score (0.90, 0.92, 1 for drug, disease and observation entity mapping respectively and perfect results for medical entity extraction and code logic consistency). These results confirm the model’s effectiveness in accurately transforming complex clinical rules into executable code. In conclusion, we successfully automated the creation of executable code from medical guidelines, proving that LLMs, supported by RAG, can be effective for automating clinical decision support tasks and formalizing medical rules
- Open Access
- 19 June 2025
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 21 (11) , 904-913
A simulation trial evaluating ABiMed, a clinical decision support system for medication reviews and polypharmacy management
- 19 June 2025
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 21 (11) , 904-913
Open AccessA simulation trial evaluating ABiMed, a clinical decision support system for medication reviews and polypharmacy management
- Open Access
- 15 May 2025
- Published by IOS Press
- Vol. 327, 118-122
Argumentation-Based Framework Selection for Clinical Decision Support
Clinical decision-making involves complex considerations, such as treatment options, patient preferences, and conflicting medical opinions. Argumentation frameworks provide a structured approach to modeling and reasoning through these complexities by constructing and evaluating arguments for and against specific decisions. This paper reviews existing AFs to identify the most suitable one for clinical decision support. We perform a comparative analysis of several frameworks—Dung’s AF, PAF, VAF, WAF, BAF, IBIS, and QuAD—using criteria tailored to clinical decision-making needs. Our analysis suggests that QuAD and DF-QuAD are those that best satisfy our criteria.
- 15 May 2025
- Published by IOS Press
- Vol. 327, 118-122
Open AccessArgumentation-Based Framework Selection for Clinical Decision Support
Clinical decision-making involves complex considerations, such as treatment options, patient preferences, and conflicting medical opinions. Argumentation frameworks provide a structured approach to modeling and reasoning through these complexities by constructing and evaluating arguments for and against specific decisions. This paper reviews existing AFs to identify the most suitable one for clinical decision support. We perform a comparative analysis of several frameworks—Dung’s AF, PAF, VAF, WAF, BAF, IBIS, and QuAD—using criteria tailored to clinical decision-making needs. Our analysis suggests that QuAD and DF-QuAD are those that best satisfy our criteria.
- Open Access
- 15 May 2025
- Published by IOS Press
- Vol. 327, 213-214
Simulation Trials for Evaluating Clinical Decision Support Systems
The evaluation of clinical decision support systems (CDSS) during randomized clinical trials in very long and complex to set up. Simulation trials consist of evaluating the CDSS on fictitious patients. While they cannot entirely replace clinical trials, they are simpler to perform and offer additional possibilities. In this paper, we present recommendations for the design of simulation trials evaluating CDSS, based on the lessons learned during two recent studies. We also propose a model of protocol that maximizes statistical power and avoids several common biases, and an R code template for statistical analysis using linear mixed models.
- 15 May 2025
- Published by IOS Press
- Vol. 327, 213-214
Open AccessSimulation Trials for Evaluating Clinical Decision Support Systems
The evaluation of clinical decision support systems (CDSS) during randomized clinical trials in very long and complex to set up. Simulation trials consist of evaluating the CDSS on fictitious patients. While they cannot entirely replace clinical trials, they are simpler to perform and offer additional possibilities. In this paper, we present recommendations for the design of simulation trials evaluating CDSS, based on the lessons learned during two recent studies. We also propose a model of protocol that maximizes statistical power and avoids several common biases, and an R code template for statistical analysis using linear mixed models.
- Open Access
- 23 April 2025
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 25 (1) , 1-14
ABiMed: An intelligent and visual clinical decision support system for medication reviews and polypharmacy management
Polypharmacy can be both a public health and an economic issue. Medication reviews are structured interviews of the patient by the pharmacist, aiming at optimizing the drug treatment and deprescribing potentially inappropriate medications. However, they remain difficult to perform and time-consuming. Several clinical decision support systems were developed for helping clinicians to reduce inappropriate polypharmacy. However, most were limited to the implementation of clinical practice guidelines. In this work, our objective is to design an innovative clinical decision support system for medication reviews and polypharmacy management, named ABiMed. ABiMed associates several approaches: guidelines implementation, but also the automatic extraction of patient data from the GP’s electronic health record and its transfer to the pharmacist, and the visual presentation of contextualized drug knowledge using visual analytics. We performed an ergonomic assessment and qualitative evaluations involving pharmacists and GPs during focus groups and workshops. We describe the proposed architecture, which allows a collaborative multi-user usage. We present the various screens of ABiMed for entering or verifying patient data, for accessing drug knowledge (posology, adverse effects, interactions), for viewing STOPP/START rules and for suggesting modification to the treatment. Qualitative evaluations showed that health professionals were highly interested in our approach, associating the automatic guidelines execution with the visual presentation of drug knowledge. The association of guidelines implementation with visual presentation of knowledge is a promising approach for managing polypharmacy. Future works will focus on the improvement and the evaluation of ABiMed.
- 23 April 2025
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 25 (1) , 1-14
Open AccessABiMed: An intelligent and visual clinical decision support system for medication reviews and polypharmacy management
Polypharmacy can be both a public health and an economic issue. Medication reviews are structured interviews of the patient by the pharmacist, aiming at optimizing the drug treatment and deprescribing potentially inappropriate medications. However, they remain difficult to perform and time-consuming. Several clinical decision support systems were developed for helping clinicians to reduce inappropriate polypharmacy. However, most were limited to the implementation of clinical practice guidelines. In this work, our objective is to design an innovative clinical decision support system for medication reviews and polypharmacy management, named ABiMed. ABiMed associates several approaches: guidelines implementation, but also the automatic extraction of patient data from the GP’s electronic health record and its transfer to the pharmacist, and the visual presentation of contextualized drug knowledge using visual analytics. We performed an ergonomic assessment and qualitative evaluations involving pharmacists and GPs during focus groups and workshops. We describe the proposed architecture, which allows a collaborative multi-user usage. We present the various screens of ABiMed for entering or verifying patient data, for accessing drug knowledge (posology, adverse effects, interactions), for viewing STOPP/START rules and for suggesting modification to the treatment. Qualitative evaluations showed that health professionals were highly interested in our approach, associating the automatic guidelines execution with the visual presentation of drug knowledge. The association of guidelines implementation with visual presentation of knowledge is a promising approach for managing polypharmacy. Future works will focus on the improvement and the evaluation of ABiMed.
- Open Access
- 20 December 2024
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 195, 105772
Impact on clinical guideline adherence of Orient-COVID, a clinical decision support system based on dynamic decision trees for COVID19 management: A randomized simulation trial with medical trainees
- 20 December 2024
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 195, 105772
Open AccessImpact on clinical guideline adherence of Orient-COVID, a clinical decision support system based on dynamic decision trees for COVID19 management: A randomized simulation trial with medical trainees
- Open Access
- 22 November 2024
- Published by IOS Press
- Vol. 321, 58-62
Supporting Pharmacist-GP Collaboration in Medication Review Using Argumentation
Medication review is a collaborative process between pharmacists and general practitioners (GPs) aimed at optimizing patient care by identifying and eliminating harmful medications. This paper proposes a collaborative platform to enhance pharmacist-GP interactions, assess drug-drug interactions, evaluate adverse effects, and manage dosages. The platform uses the issue mapping function of IBIS to structure dialogues and systematically evaluates proposed actions using the QuAD framework to support decision-making. An ontology based on medical knowledge ensures consistency, while visual enhancements such as varying edge width, color coding, and highlighting preferred actions enable swift, informed decisions. These tools improve collaboration and patient care outcomes.
- 22 November 2024
- Published by IOS Press
- Vol. 321, 58-62
Open AccessSupporting Pharmacist-GP Collaboration in Medication Review Using Argumentation
Medication review is a collaborative process between pharmacists and general practitioners (GPs) aimed at optimizing patient care by identifying and eliminating harmful medications. This paper proposes a collaborative platform to enhance pharmacist-GP interactions, assess drug-drug interactions, evaluate adverse effects, and manage dosages. The platform uses the issue mapping function of IBIS to structure dialogues and systematically evaluates proposed actions using the QuAD framework to support decision-making. An ontology based on medical knowledge ensures consistency, while visual enhancements such as varying edge width, color coding, and highlighting preferred actions enable swift, informed decisions. These tools improve collaboration and patient care outcomes.